Is my portfolio
One Report to Answer all your Questions!
Alivus Life Sciences Ltd.
BSE: 543322 | NSE: ALIVUS
Small Cap | Pharmaceuticals & Drugs
912.60
1.55 (0.17%) Glenmark Life Sciences informs about disclosure
Date: 16-07-2024Glenmark Life Sciences has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 15, 2024 for Glenmark Pharmaceuticals.
The above information is a part of company’s filings submitted to BSE.